SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter

被引:218
|
作者
Trotti, D
Rolfs, A
Danbolt, NC
Brown, RH
Hediger, MA
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Med, Membrane Biol Program, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal, Boston, MA 02115 USA
[3] Univ Oslo, Inst Basic Med Sci, Dept Anat, N-0317 Oslo, Norway
[4] Harvard Univ, Massachusetts Gen Hosp E, Sch Med, Day Neuromuscular Res Lab, Charlestown, MA 02129 USA
关键词
D O I
10.1038/8091
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The mechanism by which Cu2+/Zn2+ superoxide dismutase (SOD1) mutants lead to motor neuron degeneration in familial amyotrophic lateral sclerosis (FALS) is unknown. We show that oxidative reactions triggered by hydrogen peroxide and catalyzed by A4V and I113T mutant but not wild-type SOD1 inactivated the glutamate transporter human GLT1. Chelation of the copper ion of the prosthetic group of A4V prevented GLT1 inhibition. GLT1 was a selective target of oxidation mediated by SOD1 mutants, and its reactivity was confined to the intracellular carboxyl-terminal domain. The antioxidant Mn(III)TBAP rescued GLT1 from inhibition. Because inactivation of GLT1 results in neuronal degeneration, we propose that toxic properties of SOD1 mutants lead to neuronal death via an excitotoxic mechanism in SOD1-linked FALS.
引用
收藏
页码:427 / 433
页数:7
相关论文
共 50 条
  • [41] A novel SOD1 mutation in familial amyotrophic lateral sclerosis.
    Hung, WY
    Yang, Y
    Kaplan, JP
    Deng, G
    Deng, HX
    Siddique, N
    Eisen, A
    Siddique, T
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A410 - A410
  • [42] A novel SOD1 gene mutation in familial amyotrophic lateral sclerosis
    Murakami, T
    Nagano, I
    Shoji, M
    Abe, K
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S58 - S58
  • [43] What is the clinical significance of SOD1 mutations in amyotrophic lateral sclerosis?
    Orrell, Richard W.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (05): : 473 - 473
  • [44] SOD1 in Amyotrophic Lateral Sclerosis: "Ambivalent" Behavior Connected to the Disease
    Pansarasa, Orietta
    Bordoni, Matteo
    Diamanti, Luca
    Sproviero, Daisy
    Gagliardi, Stella
    Cereda, Cristina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [45] SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis
    Rouleau, GA
    Clark, AW
    Rooke, K
    Pramatarova, A
    Krizus, A
    Suchowersky, O
    Julien, JP
    Figlewicz, D
    ANNALS OF NEUROLOGY, 1996, 39 (01) : 128 - 131
  • [46] Structural and Functional Analysis of Human SOD1 in Amyotrophic Lateral Sclerosis
    Alves Moreira, Lorenna Giannini
    Pereira, Livia Costa
    Drummond, Priscila Ramalho
    De Mesquita, Joelma Freire
    PLOS ONE, 2013, 8 (12):
  • [47] SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis
    Tafuri, Francesco
    Ronchi, Dario
    Magri, Francesca
    Comi, Giacomo P.
    Corti, Stefania
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9
  • [48] Prion Properties of SOD1 in Amyotrophic Lateral Sclerosis and Potential Therapy
    Sibilla, Caroline
    Bertolotti, Anne
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2017, 9 (10):
  • [49] SOD1 mutation and clinical features of familial amyotrophic lateral sclerosis
    Abe, K
    Warita, H
    Murakami, T
    Hayashi, T
    Sato, K
    Manabe, Y
    MOLECULAR MECHANISM AND THERAPEUTICS OF AMYOTROPHIC LATERAL SCLEROSIS, 2001, 1221 : 117 - 122
  • [50] Current status of SOD1 mutations in familial amyotrophic lateral sclerosis
    Gaudette, M
    Hirano, M
    Siddique, T
    AMYOTROPHIC LATERAL SCLEROSIS, 2000, 1 (02): : 83 - 89